Immd Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Food and Beverage Stores | Other Direct Selling Establishments | Rental and Leasing Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Management of Companies and Enterprises

Full name: Immd Sp. z o.o.

Profile Updated: March 21, 2025

Immd Sp. z o.o. is a company in Poland, with a head office in Warsaw. The enterprise operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The enterprise was incorporated on November 19, 2013. It currently has a total number of 1 (2015) employees. During that time, Immd Sp. z o.o.’s total assets decreased by 99.32%.

Headquarters
Ul. Stefana Batorego 18/108
Warsaw; Mazowieckie; Postal Code: 02-591

Contact Details: Purchase the Immd Sp. z o.o. report to view the information.

Basic Information

Total Employees:

Purchase the Immd Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Immd Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Immd Sp. z o.o. report to view the information.

Incorporation Date:

November 19, 2013

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Immd Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Total operating revenue

4300.59%▲

Operating profit (EBIT)

90.07%▲

EBITDA

89.95%▲

Net Profit (Loss) for the Period

63.5%▲

Total Assets

-99.32%▼

Total Equity

-16.72%▼

Return on Equity (ROE)

-30.64%▼

Similar companies